Carboplatin and Paclitaxel With or Without ISIS 3521 in Treating Patients With Non-Small Cell Lung Cancer

NCT00017407 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Lung Cancer

Interventions

BIOLOGICAL: ISIS 3521
DRUG: carboplatin
DRUG: paclitaxel

Sponsor

Ionis Pharmaceuticals, Inc.